The FDA Modernization Act of 1997 reauthorized the collection of user fees by the FDA and amended the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices and biological products, and to facilitate the development and evaluation of new drugs designed to treat serious and life-threatening illnesses.